Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02138617
Title Genotype-Directed Study Of Irinotecan Dosing In FOLFIRI + BevacizumabTreated Metastatic Colorectal Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors UNC Lineberger Comprehensive Cancer Center
Indications

colon adenocarcinoma

rectum adenocarcinoma

Therapies

Leucovorin

Bevacizumab

Irinotecan

Fluorouracil

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
IU Simon Cancer Center Indianapolis Indiana 46202 United States Details
IU Arnett Hospital Lafayette Indiana 47905 United States Details
University of North Carolina Chapel Hill North Carolina 27599 United States Details
Carolina Healthcare Systems Charlotte North Carolina 28204 United States Details
Cone Health Cancer Center Greensboro North Carolina 27403 United States Details
Rex Healthcare Raleigh North Carolina 27607 United States Details
Bon Secours Cancer Institute Midlothian Virginia 23114 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field